[Vasopeptidase inhibitors. Clinical implications of a new class of drugs]

Dtsch Med Wochenschr. 2000 Apr 20;125(16):499-503. doi: 10.1055/s-2007-1024289.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Animals
  • Atrial Natriuretic Factor / blood
  • Cardiovascular Diseases / drug therapy*
  • Disease Models, Animal
  • Heart Failure / drug therapy
  • Humans
  • Hypertension / drug therapy
  • Neprilysin / antagonists & inhibitors*
  • Renin-Angiotensin System / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Atrial Natriuretic Factor
  • Neprilysin